Breast cancer molecular diagnostics in Rwanda: a cost-minimization study of immunohistochemistry versus a novel GeneXpert(®) mRNA expression assay

OBJECTIVE: To compare the financial and time cost of breast cancer biomarker analysis by immunohistochemistry with that by the Xpert(®) STRAT4 assay. METHODS: We estimated costs (personnel, location, consumables and indirect) and time involved in breast cancer diagnosis at the Butaro Cancer Centre o...

Descripción completa

Detalles Bibliográficos
Autores principales: Erfani, Parsa, Gaga, Esther, Hakizimana, Emmanuel, Kayitare, Emmanuel, Mugunga, Jean Claude, Shyirambere, Cyprien, Milner, Dan A, Shulman, Lawrence N, Ruhangaza, Deogratias, Fadelu, Temidayo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Health Organization 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795380/
https://www.ncbi.nlm.nih.gov/pubmed/36593782
http://dx.doi.org/10.2471/BLT.22.288800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795380/
https://www.ncbi.nlm.nih.gov/pubmed/36593782
http://dx.doi.org/10.2471/BLT.22.288800

Ejemplares similares